A randomized, double-blind, controlled trial of testosterone gel treatment versus vehicle control on the facial hair of young men with beta-thalassemia major

Journal of Dermatological Treatment

Volumn 18, Issue 5, 2007, Pages 271-274

  Saeedi, Majid ^a,b   Kosaryan, Mehrnoush ^a   Fekri, Kiavash ^a   Adabi, Morteza ^a   Mahdavi, Mohamad Reza ^a  

^a MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Faculty of Pharmacy   (Iran)

Author keywords

Beard; Hypogonadism; SMR; Testosterone gel; Thalassemia major; Treatment

Indexed keywords

TESTOSTERONE;

ADULT; AGE DISTRIBUTION; ARTICLE; BETA THALASSEMIA; BLOOD TRANSFUSION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; HAIR; HAIR GROWTH; HORMONE DEFICIENCY; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEXUAL FUNCTION; STATISTICAL SIGNIFICANCE; STUDENT T TEST; TESTOSTERONE BLOOD LEVEL; TESTOSTERONE DEFICIENCY; THALASSEMIA MAJOR;

ADOLESCENT; ADULT; ANDROGENS; BETA-THALASSEMIA; DOUBLE-BLIND METHOD; FACE; GELS; HAIR; HUMANS; HYPOGONADISM; HYPOTRICHOSIS; MALE; TESTOSTERONE; TREATMENT OUTCOME;

EID: 35148840642     PISSN: 09546634     EISSN: 14711753     Source Type: Journal    
DOI: 10.1080/09546630701567378     Document Type: Article

References (20)

1. Low Louis CK. Growth of children with β-thalassemia major. Indian J Pediatr. 2005;72:159-64.
2. Bazrafshan HR, Mohammadian S, Azizi F, Mehrabi Y. Delayed puberty in patients with thalassemia major. J Mazandaran Uni Med Sci. 1999;24:39-43.
3. Abdulrazzaq YM, Ibrahim A, Al-Khayat AI, Dawson K. β-Thalassemia major and its effect on amino acid metabolism and growth in patients in the United Arab Emirates. Clin Chim Acta. 2005;352(1-2): 183-90.
4. Shalitin S, Carmi D, Weintrob N, Phillip M, Miskin H, Kornreich L, et al. Serum ferritin level as a predictor of impaired growth and puberty in thalassemia major patients. Eur J Haematol. 2005;74:93-100.
5. Soliman AT, Nasr I, Thabet A, Rizk MM, Matary WE. Human chorionic gonadotropin therapy in adolescent boys with constitutional delayed puberty vs those with β-thalassemia major. Metab Clin Exp. 2005;54:15-23.
6. Jordan WP, Atkinson LE, Lai C. Comparison of the skin irritation potential of two testosterone transdermal systems: An investigational system and a marketed product. Clin Ther. 1998;20:80-7.
7. Khodai S, Karbakhsh M, Asasi N. Psychosocial status in Iranian adolescents with beta-thalassemia major. J Fac Med (Tehran Uni Med Sci). 2005;63:18-23.
8. Slater CC, Souter I, Zhang C, Guan C, Stanczyk FZ, Mishell DR. Pharmacokinetic of testosterone after percutaneous gel or buccal administration. Fertil Steril. 2001;76:32-7.
9. Galasso F, Altamura V, Sbano E. Effects of topical testosterone propionate on the positive nickel patch test. J Dermatol Sci. 1996;13:76-82.
10. Saeedi M, Morteza-Semnani K, Ghoreishi MR. The treatment of atopic dermatitis with licorice gel. J Dermatol Treat. 2003;14:153-7.
11. Kattamis AC, Antoniadis M, Manoli I, Kitra V, Petropoulos D, Grafacos S. Endocrine problem in exthalassemic patients. Transfus Sci. 2000;23:251-2.
12. Anoussakis C, Alexiou D, Abatzis D, Bechrakis G. Endocrinological investigation of pituitary conadal axis in thalassemia major. Acta Pediatr Scand. 1977;66:49-51.
13. Marin P, Holmang S, Jonsson L, Sjostrom L, Kvist H, Holm G, et al. The effect of testosterone treatment on body composition and metabolism in middle-aged obese men. Int J Obes. 1992;16:991-7.
14. Valenti S, Giusti M, McGuinness D, Guido R, Mori PG, Giordano G, et al. Delayed puberty in males with beta-thalassemia major: Pulsatile gonadotropin-releasing hormone administration induces changes in gonadotropin isoform profiles and an increase in sex steroids. Eur J Endocrinol. 1995;133:48-56.
15. Kim MK, Zhao H, Lee CH, Kim DD. Formulation of a reservoir-type testosterone transdermal delivery system. Int J Pharm. 2001;219(1-2): 51-9.
16. De Sanctis V, Vullo C, Urso L, Rigolin F, Cavallini A, Caramelli K, et al. Clinical experience using the andoderm testosterone transdermal system in hypogonadal adolescents and young men with beta-thalassemia major. J Pediatr Endocrinol Metab. 1998;11:891-900.
17. Moore N, Paux G, Noblet C, Andrejak M. Spouce related drug side effects. Lancet. 1988;27:468.
18. Delanoe D, Fougeyrollas B, Meyer L, Thonneau P. Androgenization of female partners of men on medroxyprogesterone acetate/percutaneous testosterone contraception. Lancet. 1984;24:276.
19. Bennett NJ. A burn-like lesion caused by a testosterone transdermal system. Burns. 1998;24:478-80.
20. Wilson DE, Kaidbey K, Boike SC, Jorkasky DK. Use of topical corticosteroid pretreatment to reduce the incidence and severity of skin reactions associated with testosterone transdermal therapy. Clin Ther. 1998;20:299-306.